NL
Neil Lerner
Chief Accounting Officer

Neil Lerner insider trades: Compass Therapeutics (CMPX) stock buys and sales

Chief Accounting Officer, Compass Therapeutics Last trade Oct 1, 2026 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$50K
Bought, last 12 months
3 buys
11
Open-market trades
since 2011
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Neil reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 1, 2026CMPX↑ Buy$18K
Sep 24, 2026CMPX↑ Buy$3K
Apr 29, 2026CMPX↑ Buy$28K
Apr 7, 2025CMPX↑ Buy$28K
Mar 12, 2019PMD↓ Sell$137K
May 22, 2018PMD↓ Sell$98K
Nov 18, 2016PMD↓ Sell$74K
Sep 10, 2015PMD↑ Buy$31K
Jun 15, 2012PMD↑ Buy$25K
May 25, 2011PMD↑ Buy$59K
Mar 17, 2011PMD↑ Buy$18K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CMPX insiders

Open-market trades in the last 12 months

About Neil Lerner's insider trades

Neil Lerner is Chief Accounting Officer at Compass Therapeutics (CMPX). Since Mar 17, 2011, Neil has reported 8 open-market purchases worth $211K and 3 sales worth $309K on SEC Form 4. In the last 12 months: 3 buys ($50K).

Their filings also include shares withheld for taxes (15 filings), grants and awards (14 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMPX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.